Search - tctmd.com

Displaying 81 - 100 of 2240

Sort: Relevancy | Date

Presentation TCT 2016

Designing a Complication-Free DCB: Is It Possible or Necessary?

Presenter: Koen Deloose, William A. Gray, Juan F. Granada

November 01, 2016

Presentation TCT 2016

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application

Presenter: Koen Deloose, William A. Gray, Mahmood K. Razavi

November 01, 2016

Presentation TCT 2016

Bioabsorbable Vascular Scaffolds: Landscape in 2016

Presenter: Sripal Bangalore, George D. Dangas, Alexandre Abizaid

November 01, 2016

Presentation TCT 2016

TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials

Presenter: Serban Puricel, Clemens von Birgelen

November 01, 2016

Presentation TCT 2016

TCT 387: Sirolimus-Coated Balloons for the Prevention of Vascular Restenosis in Small Vessel Disease: Insights From the Nanoluté Registry

Presenter: Germano Di Sciascio, Bruno Scheller

November 01, 2016

Presentation TCT 2016

TCT 312: Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An Analysis of the BASKET-PROVE I and II trials.

Presenter: Serban Puricel, Clemens von Birgelen

November 01, 2016

Presentation TCT 2016

TCT 401: Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with Bioresorbable Scaffolding Platforms in Europe) Registry

Presenter: Serban Puricel, Clemens von Birgelen

November 01, 2016

Presentation TCT 2016

TCT 388: Sirolimus Coated Balloon in the Treatment of Acute Coronary Syndrome: Results from the Nanolutè Registry

Presenter: Germano Di Sciascio, Bruno Scheller

November 01, 2016

Presentation TCT 2016

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up

Presenter: Fernando Alfonso, Ran Kornowski, Pieter R. Stella

November 01, 2016

Presentation TCT 2016

Nanoparticle Sirolimus Coated Balloon for the Treatment of In-Stent Restenosis: Results from the Nanolute Registry

Presenter: Fernando Alfonso, Ran Kornowski, Bernardo Cortese

November 01, 2016

Presentation TCT 2016

TCT 402: Relationship Between Bioresorbable Scaffold Sizing and Scaffold Thrombosis: A Pooled Analysis of ABSORB Trials

Presenter: Serban Puricel, Clemens von Birgelen

November 01, 2016

Presentation TCT 2016

Back to BRS: Falcon, the Next Generation

Presenter: Ron Waksman, Robert-Jan van Geuns, Richard J. Rapoza

October 31, 2016

Presentation TCT 2016

BRS Snapshots: A Novel Biodegradable FE/316L Stent

Presenter: Ron Waksman, Robert-Jan van Geuns, Olivier F. Bertrand

October 31, 2016

Presentation TCT 2016

BRS Snapshots: Lifetech Iron-Based BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Runlin Gao

October 31, 2016

Presentation TCT 2016

BRS Snapshots: ArterioSorb

Presenter: Ron Waksman, Robert-Jan van Geuns, Patrick W. Serruys

October 31, 2016

Presentation TCT 2016

BRS Snapshots: The Biolute BRS

Presenter: Ron Waksman, Robert-Jan van Geuns, Dinesh Shah

October 31, 2016

Presentation TCT 2016

BRS Snapshots: XINSORB

Presenter: Ron Waksman, Robert-Jan van Geuns, Lei Ge

October 31, 2016

Presentation TCT 2016

BRS Snapshots: ART and Progress Toward a Drug-Eluting Device

Presenter: Ron Waksman, Robert-Jan van Geuns, Antoine Lafont

October 31, 2016

Presentation TCT 2016

BRS Snapshots: Renuvia FAST

Presenter: Ron Waksman, Robert-Jan van Geuns, Ian T. Meredith

October 31, 2016

Presentation TCT 2016

NeoVas PLLA-Based Sirolimus-Eluting Scaffold: Early Results and Phase III Completion

Presenter: Ron Waksman, Robert-Jan van Geuns, Guosheng Fu

October 31, 2016

Advertisement

Designing a Complication-Free DCB: Is It Possible or Necessary?

DCB in BTK Intervention: Necessary Technical and Clinical Improvements to Unlock" the BTK Application

Bioabsorbable Vascular Scaffolds: Landscape in 2016

TCT 313: Incidence and Predictors of Very Late Major Adverse Cardiac Events After Metallic Stents: A Patient-Level Pooled Analysis from Seventeen Randomized Trials

TCT 387: Sirolimus-Coated Balloons for the Prevention of Vascular Restenosis in Small Vessel Disease: Insights From the Nanoluté Registry

TCT 312: Increased Cardiac Death and Stent Thrombosis in Chronic Obstructive Pulmonary Disease Patients Undergoing Percutaneous Coronary Intervention. An Analysis of the BASKET-PROVE I and II trials.

TCT 401: Bioresorbable Scaffolds And Thrombosis: Insights From The GHOST-EU (Gauging coronary Healing with Bioresorbable Scaffolding Platforms in Europe) Registry

TCT 388: Sirolimus Coated Balloon in the Treatment of Acute Coronary Syndrome: Results from the Nanolutè Registry

Sirolimus Angioplasty Balloon for In-Stent Restenosis (SABRE) Trial: 6-Month Angiographic and 1-Year Clinical Follow Up

Nanoparticle Sirolimus Coated Balloon for the Treatment of In-Stent Restenosis: Results from the Nanolute Registry

TCT 402: Relationship Between Bioresorbable Scaffold Sizing and Scaffold Thrombosis: A Pooled Analysis of ABSORB Trials

Back to BRS: Falcon, the Next Generation

BRS Snapshots: A Novel Biodegradable FE/316L Stent

BRS Snapshots: Lifetech Iron-Based BRS

BRS Snapshots: ArterioSorb

BRS Snapshots: The Biolute BRS

BRS Snapshots: XINSORB

BRS Snapshots: ART and Progress Toward a Drug-Eluting Device

BRS Snapshots: Renuvia FAST

NeoVas PLLA-Based Sirolimus-Eluting Scaffold: Early Results and Phase III Completion

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content